A treat and extend protocol with Aflibercept for cystoid macular oedema secondary to central retinal vein occlusion – an 18-month prospective cohort study

BACKGROUND: To evaluate the safety and efficacy of a treat-and-extend protocol of aflibercept for cystoid macular oedema (CMO) secondary to central retinal vein occlusion (CRVO). METHODS: Twenty patients with CMO secondary to CRVO were included in this prospective cohort study. After 3 loading 4-wee...

Descripción completa

Detalles Bibliográficos
Autores principales: O’Day, Roderick, Ali, Noha, Lim, Lyndell L., Sandhu, Sukhpal, Chau, Thuy, Wickremasinghe, Sanjeewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038604/
https://www.ncbi.nlm.nih.gov/pubmed/32093666
http://dx.doi.org/10.1186/s12886-020-01346-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038604/
https://www.ncbi.nlm.nih.gov/pubmed/32093666
http://dx.doi.org/10.1186/s12886-020-01346-8

Ejemplares similares